BackRubius Therapeutics Overview

Rubius Therapeutics Other Income Expense Net

See how RUBY's other income/expense trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Quarterly Other Income/Expense

-$20.01M
1446.6% YoY

As of Dec 31, 2022

Annual Other Income/Expense (TTM)

-$24.19M
974.83% YoY

Trailing 12 months ending Dec 31, 2022

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Rubius Therapeutics (RUBY) FAQ

Stockcircle tracks other income & expense for Rubius Therapeutics (RUBY), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Other Income & Expense page is built for Rubius Therapeutics's historical other income/expense trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use other income/expense as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main RUBY overview so you can move from this figure to the surrounding analysis quickly.